jsxmn.cn-亚洲中文字幕久久精品无码A,亚洲av无码一区二区三区dv,国产在线精品一区二区,激情伊人五月天久久综合

產品展示 / products 您的位置:網站首頁 > 產品展示 > 細胞庫 > 細胞系 > 人肺扁平上皮癌細胞QG-56
產品分類

Product category

相關文章

Related articles

人肺扁平上皮癌細胞QG-56

人肺扁平上皮癌細胞QG-56

簡要描述:青旗(上海)生物技術發展有限公司,總部位于上海浦東新區,依托本地高校資源,逐步發展成為以生物技術為主的研發、生產、培訓為一體的綜合化產業平臺,在標準化細胞庫建立及細胞藥物前端模型方面成果顯著。公司生產經營原代細胞、細胞系、ELISA試劑盒、感受態細胞和HPLC檢測等科研產品與服務。我們秉承對用戶負責的態度,以對科研的高度嚴謹,以嚴格的質量控制,為廣大生物醫學科研用戶提供更優質的服務!

更新時間:2021-05-24

廠商性質:生產廠家

瀏覽次數:405

詳情介紹
品牌其他品牌貨號BFN60806944
規格T25培養瓶x1 1.5ml凍存管x2供貨周期現貨
主要用途僅供科研應用領域醫療衛生,生物產業

細胞名稱

人肺扁平上皮癌細QG-56

img1

貨物編碼

BFN60806944

產品規格

T25培養x1

1.5ml凍存x2

細胞數量

1x10^6

1x10^6

保存溫度

37

-198

運輸方式

常溫保溫運輸

干冰運輸

安全等級

1

用途限制

僅供科           2

 

培養體系

DMEM高糖培養+10%FBS+1% 

培養溫度

37

二氧化碳濃度

5%

簡介

人肺扁平上皮癌細QG-56取自女性供體

注釋

倍增時37h

基因突變

TP53 p.Arg249Ser (c.747G>T) (PubMed=12794755).

HLA信息

Class I

HLA-A        A*26:01

HLA-B        B*46:01

HLA-C        C*01:02

STR信息

/

參考文獻

PubMed=229054; DOI=10.20772/cancersci1959.70.4_533

Yanagawa E., Yasumoto K., Manabe H., Nagano N., Hirota N., Ohta M., Hattori T., Nomoto K., Azuma I., Yamamura Y.

Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.

Gann 70:533-539(1979)

 

PubMed=3986962; DOI=10.1093/carcin/6.4.549

Watatani M., Ikenaga M., Hatanaka T., Kinuta M., Takai S.-I., Mori T., Kondo S.

Analysis of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of Mer xenografts in athymic nude mice.

Carcinogenesis 6:549-553(1985)

 

PubMed=1778766; DOI=10.1111/j.1349-7006.1991.tb01816.x

Takeshima E., Hamaguchi M., Watanabe T., Akiyama S., Kataoka M., Ohnishi Y., Xiao H.Y., Nagai Y., Takagi H.

Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells.

Jpn. J. Cancer Res. 82:1428-1435(1991)

 

PubMed=1737336

Yoshino I., Yano T., Murata M., Ishida T., Sugimachi K., Kimura G., Nomoto K.

Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.

Cancer Res. 52:775-781(1992)

 

PubMed=8385084; DOI=10.1111/j.1349-7006.1993.tb02851.x

Suzuki S., Takahashi T., Nakamura S., Koike K., Ariyoshi Y., Takahashi T., Ueda R.

Alterations of integrin expression in human lung cancer.

Jpn. J. Cancer Res. 84:168-174(1993)

 

PubMed=8752176

Iguchi H., Tanaka S., Ozawa Y., Kashiwakuma T., Kimura T., Hiraga T., Ozawa H., Kono A.

An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.

Cancer Res. 56:4040-4043(1996)

 

PubMed=9023415; DOI=10.1006/cimm.1996.1062

Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.

HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.

Cell. Immunol. 175:101-110(1997)

 

PubMed=12569360; DOI=10.1038/sj.onc.1206106

Funakoshi T., Tachibana I., Hoshida Y., Kimura H., Takeda Y., Kijima T., Nishino K., Goto H., Yoneda T., Kumagai T., Osaki T., Hayashi S., Aozasa K., Kawase I.

Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.

Oncogene 22:674-687(2003)

 

PubMed=12794755; DOI=10.1002/ijc.11184

Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T.

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Int. J. Cancer 106:45-51(2003)

 

PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x

Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K.

Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.

Cancer Sci. 98:1048-1054(2007)

 

PubMed=19799608; DOI=10.1111/j.1349-7006.2009.01351.x

Kuroda K., Takenoyama M., Baba T., Shigematsu Y., Shiota H., Ichiki Y., Yasuda M., Uramoto H., Hanagiri T., Yasumoto K.

Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.

Cancer Sci. 101:46-53(2010)

青旗(上海)生物技術發展有限公司,總部位于上海浦東新區,依托本地高校資源,逐步發展成為以生物技術為主的研發、生產、培訓為一體的綜合化產業平臺,在標準化細胞庫建立及細胞藥物前端模型方面成果顯著。公司生產經營原代細胞、細胞系、ELISA試劑盒、感受態細胞和HPLC檢測等科研產品與服務。我們秉承對用戶負責的態度,以對科研的高度嚴謹,以嚴格的質量控制,為廣大生物醫學科研用戶提供更優質的服務! 



留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7